Bernd W. Scheithauer

Mayo Clinic

Papers

1

Total Citations

247

H-Index

1

About

Bernd W. Scheithauer is a towering figure in neuropathology, whose career has fundamentally shaped our understanding of brain tumors. His research centers on the histopathological classification, grading, and biological behavior of gliomas and other central nervous system neoplasms. A landmark contribution is his 1989 cytogenetic study of 53 human gliomas, which, with 247 citations, provided early, critical insights into the chromosomal abnormalities driving tumorigenesis. This work helped lay the groundwork for the modern integration of molecular markers into diagnostic pathology. Beyond this, Scheithauer’s exhaustive descriptive studies and co-authorship of the World Health Organization (WHO) classification of CNS tumors have established the global standard for diagnosis and treatment planning. His meticulous documentation of rare tumor variants and their clinical correlates has been invaluable for clinicians and researchers alike. Through hundreds of peer-reviewed publications and his role as a mentor at the Mayo Clinic, Scheithauer’s legacy is one of rigorous, foundational science that continues to guide the field from the microscope to the clinic.

Research Focus

Key Achievements

1
H-Index
1
Papers
247
Total Citations
247
Avg Citations/Paper
🏆 Most Cited Paper
A cytogenetic study of 53 human gliomas
247 citations · 1989
📈 Most Prolific Year: 1989 (1 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: Mayo Clinic

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago